lundi 26 août 2019

$572 Million Decision Against Johnson & Johnson in Landmark Opioid Trial

The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits.

from NYT > Health https://ift.tt/2U72j66
via health&fitness

Aucun commentaire:

Enregistrer un commentaire